Recent studies implicate CD4+CD25+ regulatory T cells (TREG) within the tumour microenvironment in suppression of CD4+ and CD8+ T-cell activation and proliferation (Shevach et al, 2001). The gene discussed is CD8A; the disease is neoplasm.